Syndrome of bloating: causes and possibilities of treatment


Cite item

Full Text

Abstract

The results of clinical study of drug Meteospasmyl recommended for the treatment of patients with irritable bowel syndrome (IBS) with a predominance of pain and bloating are presented. The study included 53 patients with different clinical variants of IBS. The results showed that Meteospazmil demonstrates high efficiency in pain and bloating relief, and it can be considered as a drug of choice in the treatment of patients with abdominal pain syndrome and increased aerogenesis.

References

  1. Баранская Е.К. Боль в животе: клинический подход к больному и алгоритм лечения. Место спазмолитической терапии в лечении абдоминальной боли // Фарматека. 2005. № 14. С. 49-57.
  2. Головенко О.В., Михайлова Т.Л., Подмаренкова Л.Ф. и др. Клиническое значение висцеральной гиперчувствительности при синдроме раздраженного кишечника // Колопроктология. 2004. № 3 (9). С. 27-30.
  3. Маев И.В., Черемушкин С.В. Лебедева Е.Г. Синдром раздраженного кишечника // Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2000. № 5. С. 70-75.
  4. Макарчук П.А. Сравнительная оценка эффективности спазмолитиков при синдроме раздраженного кишечника. Дисс. канд. мед. наук. М., 2007. 90 с.
  5. Минушкин О.Н. Метеоспазмил и его место в лечении больных с синдромом раздраженного кишечника // Экспериментальная и клиническая гастроэнтерология. 2001. № 1. С. 34-36.
  6. Фролькис А.В. Функциональные заболевания желудочно-кишечного тракта. Л., 1991. 224 с.
  7. Akehurst R, Kaltenthaler E. Treatment of IBS: a review of randomized controlled trials. Gut. 2001;48:272-82.
  8. Bommelaer G, Rouch M, Dapoighy M, et al. Epidimiology of functional bowel disorders in apparently healthy people. Gastroenterol Clin Biol 1986;10:7-12.
  9. Bouin M, Plourde V. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771-77.
  10. Delvaux М. Do we need to perform rectal distention tests to diagnose IBS in clinical practice? Gastroenterology 2002;122:2075-78.
  11. Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology 2006;130(5):1377-90.
  12. Drossman DA, Camilli M, Whitehead WE. American Gastroenterological Association technical review on irritable bowel syndrome. Gastroenterology 1998;95:701-08.
  13. Farthing MJ. New drugs in the management of the irritable bowel syndrome. Drugs 1998;56(1):11-21.
  14. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infection irritable bowel syndrome. Gut 2003;52:523-26.
  15. Jailwala J, Imperiale T, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-47.
  16. Knowles JB, Douglas A. Drossman. Irritable bowel syndrome: diagnosis and treatment. In: Evidence based Gastroenterology and Hepatology. Edited by J. McDonald, A. Burnoughs, B. Hagan. London, BMJ Books 1999;241:260.
  17. Park JH. Review article: irritable bowel syndrome. J Gastroenterol Hepatol 2006;4:24-29.
  18. Karlbom U, Pahlman L, Nilsson S, et al. Relationships between defecographic findings, rectal empting and colonic transit time in constipated patients. Gut 1995;36(6):907-12.
  19. Kay L, Jorgensen T, Jensen KN. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23-30.
  20. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999;94:1320-26.
  21. McKendnck MW, Read NW. Irritable bowel syndrome-post Salmonella infection. Infection 1994;29:1-3.
  22. Mertz H. Altered CNS processing of visceral pain in IBS. In: Michael Camilleri and Robin C Spiller ed. Irritable bowel syndrome diagnosis and treatment. WB Saunders 2002:55-68.
  23. Naliboff BD, Munakata J, Fullerton S, et al. Evidence for two distinct perceptual alterations in IBS. Gut 1997;41:505-12.
  24. Talley NJ, Gabriel SE, Harsmen WS, et al. Medical cost in community subjects with IBS. Gastroenterology 1995;109:1736-41.
  25. Wilson A, Longstreth G, Knight K, et al. Quality of life in managed care patients with irritable bowel syndrome. Manage Care Interface 2004;17:24-28.
  26. Whitehead WE, Crowell MD, Davidoff AL, et al. Pain from rectal distension in women with irritable bowel syndrome. Dig Dis Sa 1997;42:796-804.
  27. http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2197&mid=1085056570&magid=165

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies